This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
BDNF exon IV promoter methylation and antidepressant action: a complex interplay
Clinical Epigenetics Open Access 26 December 2022
-
Synaptic plasticity and mental health: methods, challenges and opportunities
Neuropsychopharmacology Open Access 09 July 2022
-
Interplay of Val66Met and BDNF methylation: effect on reward learning and cognitive performance in major depression
Clinical Epigenetics Open Access 29 July 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Krishnan V, Nestler E . Nature 2008; 455: 894–902.
Sen S, Duman R, Sanacora G . Biol Psychiatry 2008; 64: 527–532.
Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J et al. Mol Psychiatry 2011; 16: 1088–1095.
Tadić A, Wagner S, Schlicht KF, Peetz D, Borysenko L, Dreimüller N et al. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 415–420.
Dreimüller N, Schlicht KF, Wagner S, Peetz D, Borysenko L, Hiemke C et al. Neuropharmacology 2012; 62: 264–269.
Hing B, Davidson S, Lear M, Brren G, Quinn J, McGuffin P et al. Biol Psychiatry 2012; 71: 618–626.
Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ . Nat Neurosci. 2006; 9: 519–525.
Fuchikami M, Morinobu S, Segawa M, Okamoto Y, Yamawaki S, Ozaki N et al. PLoS One 2011; 6: e23881.
Lopez JP, Mamdani F, Labonte B, Beaulieu MM, Yang JP, Berlim MT et al. Mol Psychiatry 2013; 18: 398–399.
Keller S, Sarchiapone M, Zarrilli F, Videtic A, Ferraro A, Carli V et al. Arch Gen Psychiatry. 2010; 67: 258–267.
Hutchinson AN, Deng JV, Cohen S, West AE . J Neurosci 2012; 32: 14355–14363.
Acknowledgements
This work was supported by in-house research funds of the University Medical Centre Mainz and Hannover Medical School. Parts of the doctoral thesis of Konrad F. Schlicht are incorporated into this report.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
AT, KL, SB and HF are designated as inventors of the European patent number 12171541.1–2404 ‘Method for predicting response or non-response to a monoaminergic antidepressant’.
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website
Supplementary information
PowerPoint slides
Rights and permissions
About this article
Cite this article
Tadić, A., Müller-Engling, L., Schlicht, K. et al. Methylation of the promoter of brain-derived neurotrophic factor exon IV and antidepressant response in major depression. Mol Psychiatry 19, 281–283 (2014). https://doi.org/10.1038/mp.2013.58
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2013.58
This article is cited by
-
Synaptic plasticity and mental health: methods, challenges and opportunities
Neuropsychopharmacology (2023)
-
BDNF exon IV promoter methylation and antidepressant action: a complex interplay
Clinical Epigenetics (2022)
-
Interactions Among Brain-Derived Neurotrophic Factor and Neuroimmune Pathways Are Key Components of the Major Psychiatric Disorders
Molecular Neurobiology (2022)
-
Interplay of Val66Met and BDNF methylation: effect on reward learning and cognitive performance in major depression
Clinical Epigenetics (2021)
-
Striatal Shati/Nat8l–BDNF pathways determine the sensitivity to social defeat stress in mice through epigenetic regulation
Neuropsychopharmacology (2021)